Ruthenium-106 brachytherapy in treatment of uveal melanoma: 50 years of use!

被引：0
|
作者：
Le Hir, Sarah [1 ]
Menetrier, Florence [1 ]
机构：
[1] CEA DRF D3P Prositon, 18 Route Panorama, F-92265 Fontenay Aux Roses, France
来源：
12TH INTERNATIONAL CONFERENCE ON THE HEALTH EFFECTS OF INCORPORATED RADIONUCLIDES (HEIR 2018) | 2019年 / 14卷
关键词：
CHOROIDAL MELANOMA;
D O I：
10.1051/bioconf/20191407005
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ruthenium-106 plaque brachytherapy for uveal melanoma
    Tarmann, Lisa
    Wackernagel, Werner
    Avian, Alexander
    Mayer, Christoph
    Schneider, Mona
    Winkler, Peter
    Langmann, Gerald
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (12) : 1644 - 1649
  • [2] Ruthenium-106 brachytherapy and central uveal melanoma
    Grajewski, Luise
    Kneifel, Christiane
    Woesle, Markus
    Ciernik, Ilja F.
    Krause, Lothar
    INTERNATIONAL OPHTHALMOLOGY, 2025, 45 (01)
  • [3] Ruthenium-106 brachytherapy for uveal melanoma: impact of dose deviations
    Deuzeman, Heloisa H.
    Marinkovic, Marina
    Pors, Lennart J.
    Vu, T. H. Khanh
    Kerkhof, Ellen M.
    Rasch, Coen R. N.
    Bleeker, Jacob C.
    Creutzberg, Carien L.
    Beenakker, Jan-Willem M.
    Luyten, Gre P. M.
    Horeweg, Nanda
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5916 - S5919
  • [4] Ruthenium-106 brachytherapy in the treatment of central choroidal melanoma
    Grajewski, Luise
    Lothar, Krause
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [5] Apical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma
    Flanagan, Jeremy P. M.
    Fog, Lotte S.
    Astrahan, Melvin A.
    Talbot, Lachie J.
    McKay, Daniel
    Phillips, Claire
    McKenzie, John D.
    O'Day, Roderick
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (06): : e775 - e783
  • [6] Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
    Cennamo, Gilda
    Montorio, Daniela
    D' Andrea, Luca
    Farella, Antonio
    Matano, Elide
    Giuliano, Mario
    Liuzzi, Raffaele
    Breve, Maria Angelica
    De Placido, Sabino
    Cennamo, Giovanni
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [7] Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience
    Agraval, Umiya
    Sobti, Manvi
    Russell, Heather C.
    Lockington, David
    Ritchie, Diana
    Cauchi, Paul
    Kemp, Ewan G.
    Chadha, Vikas
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (01) : 74 - 78
  • [8] Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience
    Perri, P.
    Fiorica, F.
    D'Angelo, S.
    Lambert, G.
    Parmeggiani, F.
    Martini, A.
    Carpenteri, F.
    Colosimo, C.
    Micucci, M.
    Perazzini, L.
    De Gugliemo, E.
    Berretta, M.
    Sebastiani, A.
    Cartei, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (14) : 1919 - 1924
  • [9] Ruthenium-106 Plaque Brachytherapy for Uveal Melanoma: Factors Associated With Local Tumor Recurrence
    Barker, C. A.
    Francis, J. H.
    Cohen, G. N.
    Marr, B. P.
    Wolden, S. L.
    McCormick, B.
    Abramson, D. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S304 - S304
  • [10] Impact of dose rate on clinical course in uveal melanoma after Brachytherapy with ruthenium-106
    Mossboeck, Georg
    Rauscher, Thomas
    Winkler, Peter
    Kapp, Karin S.
    Langmann, Gerald
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (10) : 571 - 575
12345